- 102.6k views
Management of Delirium in Critical Care
Delirium in critical care requires prompt recognition and management due to its association with poor patient outcomes. Multidisciplinary collaboration is essential for effective delirium management in the critical care setting. The use of validated delirium assessment tools, such as the Confusion Assessment Method for ICU (CAM-ICU), aids in early detection. Identifying and addressing underlying causes, such as infections, medication interactions, and metabolic imbalances, is crucial in managing delirium. Non-pharmacological interventions, including maintaining a consistent environment and promoting sleep, can help prevent and manage delirium. When pharmacological intervention is necessary, low-dose antipsychotics like haloperidol or quetiapine are commonly used. However, caution should be exercised with antipsychotic use, especially in elderly patients, due to the risk of adverse effects. Dexmedetomidine, an alpha-2 adrenergic agonist, has shown promise in managing delirium while promoting sedation and analgesia. Regularly reassessing the patient's cognitive status and delirium risk factors is essential to tailor management strategies.
About the Speaker
Dr. Viny Kantroo
Respiratory, Critical Care and Sleep Medicine Senior Consultant Indraprastha Apollo Hospital, New Delhi
Upcoming Case Discussions
Technology Integration with Healthcare
Technology integration in healthcare is transforming the way medical services are delivered, enhancing efficiency and patient outcomes. Innovations such as telemedicine, electronic health records (EHR), and wearable devices allow for real-time monitoring and improved accessibility. Artificial intelligence (AI) and machine learning aid in early diagnosis and personalized treatment plans. Robotic surgeries and advanced imaging techniques offer precision and reduced recovery times. By combining technology with healthcare, providers can streamline operations, improve patient engagement, and deliver cost-effective care solutions.
Pediatric Obesity: Treatment Management
Treatment management for pediatric obesity combines lifestyle changes, family support, and, in severe cases, medical interventions. Family-based strategies are key, encouraging healthy eating habits, regular physical activity, and reduced screen time. Behavioral therapy helps set achievable goals and address barriers, empowering children and families to make sustainable lifestyle adjustments. Dietitians often assist in designing individualized meal plans that focus on nutrient-rich foods and limit calorie-dense options. In cases of severe obesity with related health conditions, medications or surgery may be considered, particularly for adolescents. Continuous monitoring and support from healthcare providers are essential for long-term success and health improvement.
Clinician’s Approach to Sleep Apnea
A clinician's approach to sleep apnea begins with a thorough assessment of the patient's medical history, symptoms (such as snoring, choking, and daytime fatigue), and risk factors like obesity or hypertension. Diagnosis is typically confirmed through polysomnography or home sleep apnea testing, followed by treatment strategies such as continuous positive airway pressure (CPAP), lifestyle modifications, or surgical interventions depending on the severity and type of sleep apnea.
Case Based Approach to Arthritis
A case-based approach to arthritis involves analyzing individual patient cases to tailor diagnostic and therapeutic strategies based on specific symptoms, disease progression, and underlying causes. This method enhances clinical decision-making by providing personalized treatment plans and improving patient outcomes in conditions like osteoarthritis, rheumatoid arthritis, and psoriatic arthritis.
Addressing Nutrient Requirements in Toddlers and Preschool Children
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Viny Kantroo's Talks on Assimilate
- 10th-August-2023, TIME : 5:00PM - 6:00PM
- 0
Delirium in critical care requires prompt recognition and management due to its association with poor patient outcomes. Multidisciplinary collaboration is essential for effective delirium management in the critical care setting. The use of validated delirium assessment tools, such as the Confusion Assessment Method for ICU (CAM-ICU), aids in early detection. Identifying and addressing underlying causes, such as infections, medication interactions, and metabolic imbalances, is crucial in managing delirium. Non-pharmacological interventions, including maintaining a consistent environment and promoting sleep, can help prevent and manage delirium. When pharmacological intervention is necessary, low-dose antipsychotics like haloperidol or quetiapine are commonly used. However, caution should be exercised with antipsychotic use, especially in elderly patients, due to the risk of adverse effects. Dexmedetomidine, an alpha-2 adrenergic agonist, has shown promise in managing delirium while promoting sedation and analgesia. Regularly reassessing the patient's cognitive status and delirium risk factors is essential to tailor management strategies.
- 10th-August-2023, TIME : 5:00PM - 6:00PM
- 0
Delirium in critical care requires prompt recognition and management due to its association with poor patient outcomes. Multidisciplinary collaboration is essential for effective delirium management in the critical care setting. The use of validated delirium assessment tools, such as the Confusion Assessment Method for ICU (CAM-ICU), aids in early detection. Identifying and addressing underlying causes, such as infections, medication interactions, and metabolic imbalances, is crucial in managing delirium. Non-pharmacological interventions, including maintaining a consistent environment and promoting sleep, can help prevent and manage delirium. When pharmacological intervention is necessary, low-dose antipsychotics like haloperidol or quetiapine are commonly used. However, caution should be exercised with antipsychotic use, especially in elderly patients, due to the risk of adverse effects. Dexmedetomidine, an alpha-2 adrenergic agonist, has shown promise in managing delirium while promoting sedation and analgesia. Regularly reassessing the patient's cognitive status and delirium risk factors is essential to tailor management strategies.